34. 神経線維腫症 Neurofibromatosis Clinical trials / Disease details

臨床試験数 : 133 / 薬物数 : 186 - (DrugBank : 67) / 標的遺伝子数 : 79 - 標的パスウェイ数 : 190

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-000156-35-NL (EUCTR)	18/03/2021	03/03/2020	89Zr-Bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatmen ...	89Zr-Bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatmen ...	Neurofibromatosis type 2;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]	Product Name: 89Zr-bevacizumab INN or Proposed INN: Unknown Other descriptive name: BEVACIZUMAB ZIRCONI ...	Leiden University Medical Center	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	15	Phase 2	Netherlands
2	NCT01125046 (ClinicalTrials.gov)	July 2010	7/5/2010	Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas	Phase II Trial of Bevacizumab in Patients With Recurrent or Progressive Meningiomas	Acoustic Schwannoma;Adult Anaplastic Meningioma;Adult Ependymoma;Adult Grade I Meningioma;Adult Grad ...	Biological: bevacizumab	Northwestern University	NULL	Unknown status	18 Years	N/A	All	50	Phase 2	United States

First Previous1Next Last